Durability of the SYMPLICITY HTN-1 and HTN-2 Studies - Stephan C. Bertog, MD

↳ This is a section part of Moment: CRT 2015 Technology & Innovation - Renal Denervation: Review of the Data and Lessons from the Studies

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$10.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Durability of the SYMPLICITY HTN-1 and HTN-2 Studies presented by Stephan C. Bertog, MD at CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$10.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Fellows

Session Name: Renal Denervation: Review of the Data and Lessons from the Studies

Track: Technology & Innovation

Learning Objectives

  • Updates in Renal Denervation

Other Components in this Moment

Overview
Durability of the SYMPLICITY HTN-1 and HTN-2 Studies - Stephan C. Bertog, MD
SYMPLICITY 3 Subgroups and Analysis In-Depth - David E. Kandzari, MD
EnligHTN: Results and Update on Clinical Trial Status - V. Papademetriou, MD, DSc
Insights from the Global SYMPLICITY Registry - Felix Mahfoud, MD
Lessons from the Vessix Studies - Martin B. Leon, MD
Review of the Clinical Outcome of Non-RF Technologies: Ultrasound, Local Drug Delivery, and Brachytherapy - Horst Sievert, MD
Loading Simple Education